Source: https://www.prarulebook.co.uk/pra-rules/credit-valuation-adjustment-risk/01-01-2027?p=1 · captured 2026-09-28 · checked 2026-09-28 · 7d85aec8

2201
22027
2203
22048
2205
22069
2207
220810
2209
221011
2211
2212RW
2213
221430%
2215
221635%
2217
221860%
2219
222080%
2221
222240%
2223
222445%
2225
222620%
2227
222835%
2229
223025%
2231
223235%
2233
223450%
2235
2236(7) for each bucket measure the sensitivity to the commodity vega risk factor by simultaneously shifting the volatilities for all commodities in the bucket by 1% relative to their current values and dividing the resulting change in the aggregate CVA, and the value of eligible SA-CVA hedges, by 0.01; and
2237
2238(8) for the commodity vega risk factor set the risk weights (RWk) at 100%.
2239
224001/01/2027
2241
22426
2243
2244Alternative Approach
2245
22466.1
2247
2248A firm that:
2249
2250(1) has non-centrally cleared derivatives of a notional aggregate amount less than GBP 88 billion; and
2251
2252(2) does not have permission from the PRA to use SA-CVA;
2253
2254may choose to calculate its own funds requirement for CVA risk using the alternative approach in 6.2, instead of using BA-CVA.
2255
225601/01/2027
2257
22586.2
2259
2260A firm using the alternative approach must hold an own funds requirement for CVA risk equal to 100% of the firm’s own funds requirement for counterparty credit risk calculated in accordance with either:
2261
2262(1) the Counterparty Credit Risk (CRR) Part and, if the firm has chosen to calculate its own funds requirement in respect of securities financing transactions in accordance with the Credit Risk Mitigation (CRR) Part, the Credit Risk Mitigation (CRR) Part; or
2263
2264(2) if the firm has been granted permission by the PRA to do so, the Internal Model Method set out in Section 6 of Chapter 6 of Title II of Part Three of CRR, and, if the firm has chosen to calculate its own funds requirement in respect of securities financing transactions in accordance with the Credit Risk Mitigation (CRR) Part, the Credit Risk Mitigation (CRR) Part.
2265
226601/01/2027
2267
22686.3
2269
2270For the purposes of 6.2, a firm must:
2271
2272(1) not recognise the effect of CVA hedges; and
2273
2274(2) apply the alternative approach to the firm’s entire portfolio of covered transactions.
2275
227601/01/2027
2277
22786.4
2279
2280A firm that chooses to use the alternative approach in 6.2 must notify the PRA in writing that it meets the condition in 6.1(1) prior to using the alternative approach.
2281
228201/01/2027
2283
22847
2285
2286Transitional Provisions
2287
22887.1
2289
2290A firm may, until 1 January 2030:
2291
2292(1) exclude from its calculation of own funds requirements for CVA risk transactions entered into prior to 1 January 2027 with the following counterparties:
2293
2294(a) non-financial counterparties as defined in point (9) of Article 2 of Regulation (EU) No 648/2012 and non-financial counterparties established in a third country where those transactions do not exceed the clearing threshold as specified in Article 10(3) and (4) of Regulation (EU) No 648/2012;
2295
2296(b) counterparties referred to in point (10) of Article 2 of Regulation (EU) No 648/2012 and point (1) of Article 89 of Regulation (EU) No 648/2012; and
2297
2298(c) counterparties referred to in Article 1(4) and (5) of Regulation (EU) No 648/2012 and counterparties for which the firm had been assigning a risk weight of 0% for exposures to those counterparties in accordance with Articles 114(4) and 115(2) of CRR as those Articles applied immediately before revocation by the Treasury; or
2299
2300(2) apply a final discount scalar (\[\hat{\omega}_{T}\]) to its own funds requirements for CVA risk in accordance with the following formula: